Market closed

Exicure Inc./$XCUR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Ticker

$XCUR
Trading on

Industry

Biotechnology

Employees

7

Exicure Inc. Metrics

BasicAdvanced
$82M
-
-$4.75
3.85
-
$82M
3.85
$15.91
$7.54
4.452
4.243
76.979
76.979
-274.94%
-23.23%
-197.92%
53.125
11.57
11.57
-9.128
-55.01%
1.16%
-64.76%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XCUR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Exicure Inc. stock?

Exicure Inc. (XCUR) has a market cap of $82M as of April 06, 2025.

What is the P/E ratio for Exicure Inc. stock?

The price to earnings (P/E) ratio for Exicure Inc. (XCUR) stock is 0 as of April 06, 2025.

Does Exicure Inc. stock pay dividends?

No, Exicure Inc. (XCUR) stock does not pay dividends to its shareholders as of April 06, 2025.

When is the next Exicure Inc. dividend payment date?

Exicure Inc. (XCUR) stock does not pay dividends to its shareholders.

What is the beta indicator for Exicure Inc.?

Exicure Inc. (XCUR) has a beta rating of 3.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.